InsidersTradesSigma
Egetis Therapeutics AB (publ): management transactions · Finland · FIN-FSA
Browse the full management transaction log of Egetis Therapeutics AB (publ), a listed issuer based in Finland. Shares trade on FI FI, under the supervision of FIN-FSA. Operating in the Health Care sector, Egetis Therapeutics AB (publ) has recorded 10 reports. Market capitalisation: €2.7bn. The latest transaction was disclosed on 15 May 2026 (Purchase). Among the most active insiders: Christian Sonesson. The full history is free.
10
Insider Decl.
0
Thresholds
€52,213
8 ops.
Buy Volume
€162,487
2 ops.
Sell Volume
27Σ signal
Last declaration on 15 May 2026
Declarations10 total
529,761 shares0AktieFI:A003Y632-1
Ideal exit: 5 Feb 2027 (T+270)
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
264,880 shares0AktieFI:A003Y653-1
Ideal exit: 5 Feb 2027 (T+270)
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
264,880 shares0AktieFI:A003Y615-1
Ideal exit: 5 Feb 2027 (T+270)
153,631 shares@ SEK 6.500.0043% mcap81.3% of flowAktieFI:A003Y582-1
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
119,529 shares@ €0.59480.0034% mcap86.9% of flowAktieFI:A003Y593-1
60,000 shares@ €0.35090.0010% mcap18.7% of flowAktieFI:A003U276-2
Ideal exit: 23 Aug 2026 (T+270)
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
25,000 shares@ €0.43030.0005% mcap13.1% of flowAktieFI:A003U284-1
Ideal exit: 25 Aug 2026 (T+270)
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
15,000 shares@ €0.43340.0003% mcap100.0% of flowAktieFI:A003U244-2
Ideal exit: 24 Aug 2026 (T+270)
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
25,000 shares@ €0.35720.0004% mcap100.0% of flowAktieFI:A003U240-1
Ideal exit: 23 Aug 2026 (T+270)
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
13,460 shares@ €0.36940.0002% mcap100.0% of flowAktieFI:A003P637-1
Ideal exit: 2 Mar 2026 (T+270)
10 of 10 declarations
